)
)
Alexion Pharmaceuticals Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Alexion Pharmaceuticals Inc
Access all reports
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company specializing in the development and commercialization of innovative therapies for patients with rare and severe disorders. Alexion’s core business is focused on serving individuals afflicted with ultra-rare disorders through commercializing high-quality products that are priced based on their value. Alexion Pharmaceuticals is a subsidiary of AstraZeneca, and an American pharmaceutical company headquartered in Boston, Massachusetts
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
ALXN
Country
🇺🇸 United States